Skip to content
Governance Register

← US public companies

Gillis Steven

SEC-identified person · CIK 1229592 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Kardigan, Inc. KARD Director filed 2026–2026
Seaport Therapeutics, Inc. SPTX Officer filed 2026–2026
Takeda Pharmaceutical CO LTD TAK Director filed 2026–2026
Lyell Immunopharma, Inc. LYEL Officer filed 2025–2026
Metsera, Inc. MTSR Director filed 2025–2025
Neumora Therapeutics, Inc. NMRA Officer filed 2023–2025
Prime Medicine, Inc. PRME Officer filed 2022–2025
Maze Therapeutics, Inc. MAZE Officer filed 2025–2025
Rapport Therapeutics, Inc. RAPP Officer filed 2024–2024
Boundless Bio, Inc. BOLD Officer filed 2024–2024
Sana Biotechnology, Inc. SANA Officer filed 2021–2024
DA32 Life Science Tech Acquisition Corp. DALS Officer filed 2021–2023
VBI Vaccines Inc/BC VBIV Director filed 2017–2023
Q32 Bio Inc. QTTB Director filed 2018–2023
Codiak Biosciences, Inc. CDAK Director filed 2020–2023
Erasca, Inc. ERAS Officer filed 2021–2021
Verve Therapeutics, Inc. VERV Officer filed 2021–2021
Ruthigen, Inc. RTGN Director filed 2015–2020
VBI Vaccines INC. plcc Director filed 2014–2019
Sienna Biopharmaceuticals, Inc. SNNA Officer filed 2019–2019
Phaserx, INC. PZRX Director filed 2016–2017
Bluebird bio, Inc. BLUE Director filed 2013–2015
Trubion Pharmaceuticals, Inc TRBN Director · Ex. Chair. & President filed 2006–2010

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.